Fleming in a recent email: “While our future is exciting, we must also address immediate challenges in our business. In Q3, certain markets did not fully perform as projected, while shifts in consumer spending and sentiment may create additional hurdles in Q4.
Among the trends we are monitoring are Injectable Aesthetics in the U.S. and Brazil, as well as China's economic performance. Although many factors are beyond our control, our focus must remain on what we can influence: our competitiveness, disciplined execution, and readiness to adapt as needed.”
Q4 quota from Brenner: 40% increase and here is your performance letter for missing Q3
Among the trends we are monitoring are Injectable Aesthetics in the U.S. and Brazil, as well as China's economic performance. Although many factors are beyond our control, our focus must remain on what we can influence: our competitiveness, disciplined execution, and readiness to adapt as needed.”
Q4 quota from Brenner: 40% increase and here is your performance letter for missing Q3